1-Pyrrolidinecarboxylic acid, 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-, phenylmethyl ester, (2S)-(CAS: 1420478-87-0)

This compound must comply with GHS classification, including specific hazardous properties, and with REACH regulations in the EU, which require registration, evaluation, authorization, and restriction of chemicals. In the US, FDA and EPA have specific regulations regarding the handling, storage, and disposal of this compound, including environmental and safety measures.

While direct alternatives may not be available, there are related compounds that can serve similar roles in synthesis processes. Substitutes include other carboxylic acid derivatives or similar imidazo[1,5-a]pyrazin-3-yl analogs, but these may require different handling and synthesis conditions.

The market for this compound is emerging, driven by its applications in pharmaceutical and chemical research. Research trends are focusing on its potential use in drug development, particularly in cancer therapy, and its synthesis is being optimized for scalability and efficiency.

Waste containing this compound should be collected in appropriate containers and properly labeled. For disposal, it is recommended to incinerate or use professional waste disposal services that comply with environmental regulations. Always follow local hazardous waste management guidelines and ensure proper protective measures are in place during handling.